Balancing the Benefits and Risks of Gabapentin
From CEimpact Podcast · · 29 min
This plays from the publisher's own server. We do not host a copy.
Description
As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls
GUEST Nakia Duncan, PharmD BCGP, BCPS Associate Professor/ Pain& Palliative Care Clinical Pharmacist Texas Tech Health Science Center - School of Pharmacy
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: (https://www.ceimpact.com/courses/pharmacist-subscription/) All your CE in one convenient subscription. All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/). But wait…there’s even more!
The Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/) includes: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/)
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/).
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
- If you are already enrolled in this course, click here to redeem your credit (https://learn.ceimpact.com/course-landing/####).
- To purchase the Pharmacist CE Subscription (https://www.ceimpact.com/courses/pharmacist-subscription/)and claim your CPE credit, click here (https://www.ceimpact.com/courses/pharmacist-subscription/) or to purchase this course individually, click here. (https://www.ceimpact.com/courses/)
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use. 2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving gabapentin.
Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose.
0.05 CEU/0.5 Hr UAN: 0107-0000-26-053-H01-P Initial release date: 2/23/2026 Expiration date: 2/23/2027 Additional CPE details can be found here (https://www.ceimpact.com/courses/Balancing-the-Benefits-and-Risks-of-Gabapentin).
Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)